Introduction
The mechanisms by which T lymphocytes recognize and respond to antigen are of great importance in understanding human disease and in the development of therapeutic interventions for immune-mediated diseases. The T cell response to microorganisms is fundamentally important for survival of the host. The importance of this response is exemplified by the impact of the current epidemic of the acquired immune deficiency syndrome in which a subset ofT cells is the target ofthe human immunodeficiency virus. The T cell response to polymorphic determinants of the major histocompatibility complex (MHC)' molecules represents the major barrier to the successful transplantation of solid organs and bone marrow. Inappropriate responses by T cells to self-components can lead to autoimmune disease.
During the past few years considerable progress has been made in our understanding of the molecular events involved in T cell recognition and in the processes involved in initiating the T cell response to foreign antigens. A large number of cell surface molecules on the T cell have been implicated in the recognition events that result in the initiation of a T cell response. However, of primary importance is the T cell antigen receptor (TCR) because it must be involved in the regulation of all antigen-specific T cell responses. T cell antigen receptor recognition: the unique nature ofthe ligand Unlike B lymphocytes which utilize membrane immunoglobulin to recognize antigenic determinants of native proteins, T cells use a structurally distinct clonally distributed receptor to recognize a different form of antigen on the surface of an antigen presenting cell (APC) such as a macrophage, epithelial cell, or B cell. T cells simultaneously recognize antigen as well as polymorphic determinants on a self-MHC molecule, a phenomenon termed "MHC restriction." Understanding MHC restriction requires explanation of the nature of the antigen as well the T cell receptor that not only recognizes antigen but also self-MHC molecules.
The molecular characterization ofthe antigen perceived by
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the T cell revealed that, in contrast to B cells, T cells do not recognize native protein antigens. APC's process exogenous antigens through an acidic choroquin-sensitive endosomal compartment (reviewed in reference 1). Proteolytically treated antigens or short peptides can substitute for native antigen in stimulating T cells. This is consistent with the current view that T cells recognize short peptides derived from more complex protein antigens as a result of proteolytic processing.
It is the source of the peptide that determines whether it is presented in association with class I (HLA-A, B, C) or class II (HLA-DR, DP, DQ) MHC molecules. Peptides derived from proteins synthesized endogenously within the APC, including proteins derived from viruses which have infected the cell, are presented in association with class I MHC molecules (2) . A similar situation may apply for alloantigens (3) . In contrast, peptides derived from exogenous sources or from antigens which are taken up through endocytic pathways, and proteolytically processed, are presented in association with class II MHC molecules (4).
The precise mechanisms by which MHC molecules associate with peptide antigens are not known. With a few exceptions involving class I MHC molecules (5), direct peptide binding has been demonstrated primarily with purified class II MHC molecules and peptides (6) . These peptides can associate with class II MHC molecules on the surface of the APC, an event which occurs most often experimentally in vitro, but in vivo is more often thought to occur when peptides generated within a compartment linked to the endocytic pathway interact with class II MHC molecules (4). Peptides derived from endogenously synthesized molecules appear to bind to immature forms of the heavy chain of class I molecules in a preGolgi compartment (7) . The mechanism responsible for degradation of endogenously synthesized proteins to peptides is not known (discussed in reference 2). Variability in the ability of distinct peptides to bind to polymorphic class II MHC molecules has been well documented (8) . A similar degree of specificity exists for the interaction of peptides with class I MHC molecules. The specificity of this interaction helps to explain some of the previous observations on immune response genes.
The interaction between the peptide and the MHC molecule has been most clearly delineated from the crystal structure of class I MHC molecules (9) . The structure, as might be perceived by the TCR, consists of two a helices, which contain many of the class I MHC polymorphic residues, lying on a floor of eight antiparallel , sheets. Together, the a helices and , sheets form a groove in which peptide antigen lies. A similar structural motifis thought to hold for class II MHC molecules. A model has been proposed in which distinct regions of the TCR interact separately with peptide antigen or with portions of the surrounding MHC molecule (10) .
Structure ofthe T cell antigen receptor and its function in antigen recognition
The TCR is a seven-chain molecular complex with both variable and invariant components ( Fig. 1) (13, 14) . The defective assembly of the TCR has been associated with a selective T cell immunodeficiency ( 15) .
The structural domains of Ti and CD3 responsible for their physical and functional association is of considerable interest. A feature of Ti and CD3 that may be important in their association is the unusual presence of oppositely charged amino acids within the transmembrane domains of all Ti and CD3 chains (1 1). Mutational analysis has provided evidence that the specific conserved basic residues of Ti are required for structural assembly of the complex (16) . More recent studies with chimeric molecules demonstrate that the structural and functional basis of the association between Ti and CD3 chains is contained within regions of the Ti chains containing these transmembrane domains (Tan, L., J. Turner, and A. Weiss, submitted for publication). These domains also appear to be responsible for targeting unassembled chains ofthe complex to a degradative pathway linked to the endoplasmic reticulum (17 (18, 19) . (27) . This is consistent with the strong bias of CD4 T cells, which usually function as helper cells, for antigenic peptides derived from exogenous sources or from the endocytic pathway which associate with class II MHC restricted antigens. These CD4 T cells respond to organisms which do not use host cell biosynthetic machinery.
On a distinct subset of T cells which generally do not express CD4 or CD8, 0.5-10% of peripheral T cells, another heterodimer termed the Ti y6 is associated with the CD3 complex (28 (36, 37) . Increases in Ti y/6-bearing cells have also been noted in granulomatous lesions of leprosy and cutaneous leishmaniasis (38) . Moreover, mycobacterial antigen reactivity of y/6 Ti-bearing cells isolated from rheumatoid synovial fluid or from sites of mycobacterial inoculation has been described (39, 40). Hovever, the precise role of T cells expressing Ti y6 in host immunity awaits the development of better in vitro systems and the demonstration of their polyclonal responses to well defined antigens. The role of MHC molecules or class I MHC-related CDl gene products in such antigen responses remains to be determined.
Both Ti af3 and y6 are associated with the CD3 complex.
CD3 is comprised ofthe noncovalently associated homologous 6, E, and y chains and associated disulfide-linked homo-or heterodimers of v-v or t-q chains (11, 41, 42, 43) . The v chain has little homology to the CD3 chains but is homologous to the y chain of the IgE Fc receptor which is also expressed as a disulfide-linked dimer (44) . The q chain represents an alternatively spliced protein product ofthe chain gene (45) . It has been suggested that the r-D or v-xn dimers are distinct subunits of the TCR, separate from the CD3 complex, perhaps with distinct functions in signal transduction (see below) (43, 46) . Recently, the r-s chain homodimer has also been shown to be expressed on natural killer cells in the absence of the TCR or other CD3 components (47) . On these cells, the v chain is associated with CD16 (an Fc receptor) (48, 49) or as yet unidentified proteins (47) .
It is widely assumed that CD3 plays a role in signal transduction. This notion has been supported by the observation that anti-CD3 mAbs mimic the function of antigen in activating T cells and from studies with somatic cell mutants with defective TCR-mediated signal transduction function (50, 51) . Moreover, the structural complexity of the cytoplasmic domains of the CD3 chains (40-115 amino acids) (1 1, 43) compared to the scant information contained in the cytoplasmic tails of the Ti chains (5-12 amino acids) is consistent with this notion. CD3 is presumed to receive a signal from the ligandoccupied Ti and transmit this state of receptor occupancy by activating intracellular signal transduction mechanisms. The role of conformational changes, cross-linking, or aggregation in the activation of CD3 is not known.
Genes encoding the Ti chains and theirfunctions
The genes encoding the Ti a, #, -y, and 6 chains are organized in a manner similar to immunoglobulin (Ig) genes (reviewed in reference 52 and Fig. 2 A) . During thymic ontogeny, these genes undergo recombination which involves the joining of individual variable (V), diversity (D), and joining (J) region gene segments (Fig. 2 B) . As a result, a large repertoire of distinct TCR are generated and distributed in a clonal fashion.
Rearrangement of these gene segments proceeds in an ordered and regulated process.
The mechanism of TCR gene segment recombination is similar to the one for Ig genes in pre-B cells (53) and results in the imprecise joining of the gene segments (55) .
The defect in this mouse results in profound T and B cell defects. Whether some cases of SCID in man result from defects in the process of recombination awaits further investigation. The recombinase is thought to play a role in the numerous chromosomal translocations and inversions that involve the TCR genes in T cell tumors (52) . Each of the human TCR genes has a different organization with varying degrees ofpotential diversity generated by recombination of the available V, D, and J region segments (Fig. 2) . Because the TCR is a two-chain structure, the various combinations of partner chains is quite large. However, nonrandom pairing ofthe protein products ofat least the y and 6 chains has been well documented (31, 56, 57) . This nonrandom pairing does not necessarily reflect an incompatibility of the V regions in assembly of the y and 6 chain proteins, but may result from thymic or peripheral selection.
The potential diversity of the TCR would appear much smaller than for Ig because the Ig heavy chain locus contains a much larger number of V region segments (in excess of 1,000). However, the potential repertoire of TCRs has been estimated to be much larger (reviewed in references 10 and 52). Diversity is greatly increased by flexibility at the 3' junction of V and D segment junctions when recombined to D or J segments. In addition, variable numbers of additional nucleotides frequently found at the junctions of V/D, V/J, D/D, and D/J segments greatly increase diversity of the TCR. These nucleotides, termed N regions, are added through the action ofterminal deoxynucleotidyl transferase. Finally, the ability of the 6 locus to use a variable number of D segments also greatly amplifies the potential for diversity because each segment used has flexibility at the margin of the junction and variable numbers of N-region nucleotides are added at each joint. These various mechanisms contribute to the generation of a poten- Structure (10, 52) .
The unusual organization of the a/6 locus bears special mention. The 6 C, J, and D segments are located between the J,,-and V-region segments. The a and 6 loci can share V-region segments, although only a small number of V regions actually appear to be utilized in the recombined 6 genes (28) . As a consequence of V-region segment recombination to Ja segments, the 6 region C, J, and D segments are deleted. Specific regions flanking the 6 locus have been identified which appear to play a role in 6 gene deletion (58) . In a/l TCR-bearing cells, both alleles of the 6 locus are usually deleted.
Polymorphisms in the TCR loci have been described. Use of different constant region segments as well as an allelic polymorphism of the constant region of the y gene account for the observed disulfide-and nondisulfide-linked protein products of different sizes (28) . Polymorphisms in V regions have also been observed. At least one of these polymorphisms has been associated with a human disease, multiple sclerosis (59) .
Recent studies suggest important insights into the pathogenesis and therapy of disease may be obtained by the identification of particular TCR V region segments that are preferentially used in responses to defined antigens and in autoimmunity. Progress in identifying TCR V region segments that are preferentially expressed in complex mixtures of responding T cells has come from the isolation of some TCR V region-specific monoclonal antibodies and the application of quantitative polymerase chain reaction technology. An excellent example of an oligoclonal response of pathogenic T cells is the rodent model of experimental allergic encephalomyelitis (EAE) (60) . These T cells respond to peptides derived from myelin basic protein and express a restricted set of TCR V, and V# gene segments. Development of disease has been prevented in mice by using peptide analogues of the pathogenic peptide (61) or by vaccination with synthetic peptides derived from the Va sequence of the TCR expressed by the pathogenic T cells (62) . Established active EAE in mice has been treated successfully with monoclonal antibody reactive with this V's (63) . Inspired by these studies in rodents, recent examination of patients with multiple sclerosis has suggested the involvement of oligoclonal T cell populations (64) . Toxic shock syndrome may also result from the polyclonal activation ofT cells which express particular V: region-derived products reactive with staphylococcal enterotoxins (65) . These observations suggest therapeutic approaches towards preventing or treating human diseases involving oligoclonal T cell responses.
Somatic mutation of TCR genes does not appear to occur. This is in marked contrast to Ig genes where somatic mutation plays a major role in generating antibodies with higher affinities for antigen. Somatically mutated residues in Ig are found throughout the variable region. In contrast, the overwhelming degree of variability of the TCR is contained in the sequences of the VDJ junction, comparable to the CDR3 domain of immunoglobulin which is involved in formation of the pocket of the antibody binding site. These observations led to a model for antigen recognition by the TCR, which emphasizes why somatic mutation of TCR genes would not be desirable and that the variability in the TCR should be concentrated in the VDJ junction (10) . According to this model, the TCR a and d chains assume a conformation similar to that Ig. The V regions make contact with MHC molecule a helices, whereas the VDJ junction interacts with the associated peptide. Somatic mutation would impair MHC recognition, thus explaining the absence of somatic mutation of the TCR. This model is consistent with the limited number of TCR V regions that have evolved for the requisite MHC recognition and places a greater importance upon VDJ junctional diversity for peptide antigen recognition.
Role ofthe T cell antigen receptor in signal transduction
The initiation of an immune response not only requires recognition of antigen by the TCR, but this recognition event must be translated into a transmembrane signal. This signal, in turn, leads to a cascade of intracellular events which influence cellular responses such as the transcriptional activation of lymphokine and lymphokine receptor genes, cell proliferation, or activation of the cytolytic effector mechanism. Although transmembrane signalling by the TCR may not be the sole signal transduction event required for T cell activation, it certainly must play a primary role in regulating antigen-specific activation of T cells. Defective signal transduction by the TCR has been associated with a congenital immunodeficiency syndrome (66).
Two early signal transduction pathways are activated by stimulation of the TCR: the inositol phospholipid second messenger pathway and a tyrosine kinase pathway. Stimulation of T cells by antigen or anti-TCR mAbs induces rapid, large, and sustained increases in cytoplasmic free calcium ([Ca2+[i) as well as the activation of the calcium-and phospholipid-dependent serine and threonine kinase, protein kinase C (PKC). Many studies suggest that these biochemical changes are physiologically important events initiated as a result of TCR stimulation (reviewed in reference 67). (71) and may involve the response of an ill-defined calcium channel to inositol phosphates (72) (75, 76) .
The other second messenger derived from the inositol phospholipid pathway is 1,2-diacylglycerol. Both diacylglycerol and phorbol esters activate PKC (77) . Several (81) . The function of these proteins is not known, but they may play a role in signal transduction because they do not interact with the TCR in somatic cell mutants that are defective in TCR-mediated activation of PLC.
The TCR also activates a tyrosine kinase activity that is not intrinsic to the TCR (82, 83) . Stimulation of the TCR with antigen or with mAbs results in the phosphorylation on tyrosine residues of several proteins including the TCR v chain. Candidates for the kinase include lck and fyn, members of the src family of tyrosine kinases (84, 85) . It has been shown that lck physically interacts with CD4 and CD8 (86) . Cross-linking of CD4 results in increased Ick activity and the phosphorylation of the TCR r chain (87) . Very recent studies suggest an interaction between the TCR and fyn (88) . How the TCR is coupled to the tyrosine kinase pathway is not known, but it is independent of the coupling of the TCR to PLC because hybridoma variants which are defective in TCR-induced PLC activation still activate the tyrosine kinase pathway (83) .
Insight into the function of the tyrosine kinase pathway may come from studies ofthe CD45 (T200) family ofproteins. These proteins, which are expressed on all leukocytes including T cells, have duplicated tyrosine phosphatase domains in their cytoplasmic domains (89). The regulation of a tyrosine kinase pathway could be intimately linked to the regulation of this tyrosine phosphatase. In support of this notion, a T cell clone that fails to express CD45 does not produce IL-2 or proliferate in response to antigen or anti-TCR mAb (90) . Moreover, recent studies with a CD45 negative cell line suggest that the function ofCD45 is essential for the activation ofPLC by the TCR (91) . Increased tyrosine phosphorylation oflck has been observed in some CD45 negative mutants (92) . These studies suggest that CD45 may regulate the activity of T cell tyrosine kinases and together they may have a complex relationship with the PLC that is activated by the TCR.
Whereas the relationship of the tyrosine kinase pathway and the inositol phospholipid pathway has not been established, the studies performed with CD45 negative mutants suggest that the tyrosine kinase may regulate the activation of PLC. This is supported by kinetic studies that suggest that the tyrosine kinase is activated before PLC (93) . Direct phosphorylation of PLC and its association with stimulated epidermal growth factor and the platelet-derived growth factor receptors has been observed (94) . Although the enzymatic activity of PLC was not shown to be altered by such phosphorylation, such studies suggest that this event may be important in receptor-mediated activation of the inositol phospholipid pathway. Thus, in T cells, activation of a tyrosine kinase may represent the primary event which then serves to activate or regulate PLC activity, possibly by phosphorylation.
The relative importance of the tyrosine kinase and inositol phospholipid pathways in later cellular responses associated with T cell activation is not known. The requirement and involvement of the inositol phospholipid pathway in the activation of T cells leading to IL-2 production was recently challenged by the isolation of a murine T cell hybridoma variant which produced normal levels of IL-2 upon TCR stimulation but failed to manifest detectable inositol phospholipid second messenger production (95). The explanation for the defect in this cell has been related to recent studies which indicate that a distinct form of the TCR, containing r-q dimers, is coupled to the inositol phospholipid pathway (46) .
From the studies reported to date it would appear that the activation of the inositol phospholipid pathway can lead to T cell activation responses. This has been further supported by more recent experiments in which a heterologous receptor that activates the inositol phospholipid pathway, the human muscarinic receptor subtype 1, when expressed in T cells can induce T cell activation responses (Desai, D., and A. Weiss, unpublished data). Nevertheless, in order to understand the relative contributions of the two partially characterized signal transduction pathways and any other signal transduction events regulated by the TCR as well as by other cell surface molecules on the T cell, more progress in understanding how signal transduction events initiated at the plasma membrane regulate subsequent intracellular responses is required.
Conclusion
The T cell antigen receptor is an extraordinarily complex cell surface receptor. Its importance in regulating T cell recognition and activation makes it a critical component in all host immune responses for the clinician. Moreover, the study ofthe T cell receptor has proved to be an important model not only for the immunologist, but also for the molecular geneticist to study TCR gene regulation and recombination as well as lymphokine gene regulation, for the developmental biologist to study thymic ontogeny, for the cell biologist to study the assembly of complex multichain plasma membrane proteins, and for the physiologist to study signal transduction. Thus, the study ofthe TCR is likely to yield important insights into basic biological processes and human disease.
